4.5 Article

Involvement of sialoglycans in SARS-COV-2 infection: Opportunities and challenges for glyco-based inhibitors

期刊

IUBMB LIFE
卷 74, 期 12, 页码 1253-1263

出版社

WILEY
DOI: 10.1002/iub.2692

关键词

drug design; glycobiology; protein structure; structural biology

资金

  1. Franco-Thai Mobility Program PHCSIAM [ANR-17-EURE-0003]
  2. Glyco@Alps [N41A640121]
  3. Mahidol University
  4. LABoratoiresd'EXcellence ARCANE
  5. National Research Council ofThailand
  6. [46949XM]
  7. [ANR-15-IDEX-02]

向作者/读者索取更多资源

This article reviews the current knowledge on protein-glycan interactions that facilitate SARS-CoV-2 host entry, with a special focus on sialoglycans present on both the virions and host cell surfaces. The authors also analyze how this information provides opportunities and challenges in glyco-based inhibitors.
Viral infections have been the causes of global pandemics, including the ongoing coronavirus disease 2019, which prompted the investigation into the infection mechanisms to find treatment and aid the vaccine design. Betacoronaviruses use spike glycoprotein on their surface to bind to host receptors, aiding their host attachment and cell fusion. Protein-glycan interaction has been implicated in the viral entry mechanism of many viruses and has recently been shown in SARS-CoV-2. Here, we reviewed the current knowledge on protein-glycan interactions that facilitate SARS-CoV-2 host entry, with special interest in sialoglycans present on both the virions and host cell surfaces. We also analyze how such information provides opportunities and challenges in glyco-based inhibitors.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据